Use of hyaluronan in the selection of sperm for intracytoplasmic sperm injection (ICSI): significant improvement in clinical outcomes--multicenter, double-blinded and randomized controlled trial

K C Worrilow, S Eid, D Woodhouse, M Perloe, S Smith, J Witmyer, K Ivani, C Khoury, G D Ball, T Elliot, J Lieberman, K C Worrilow, S Eid, D Woodhouse, M Perloe, S Smith, J Witmyer, K Ivani, C Khoury, G D Ball, T Elliot, J Lieberman

Abstract

Study question: Does the selection of sperm for ICSI based on their ability to bind to hyaluronan improve the clinical pregnancy rates (CPR) (primary end-point), implantation (IR) and pregnancy loss rates (PLR)?

Summary answer: In couples where ≤ 65% of sperm bound hyaluronan, the selection of hyaluronan-bound (HB) sperm for ICSI led to a statistically significant reduction in PLR.

What is known and what this paper adds: HB sperm demonstrate enhanced developmental parameters which have been associated with successful fertilization and embryogenesis. Sperm selected for ICSI using a liquid source of hyaluronan achieved an improvement in IR. A pilot study by the primary author demonstrated that the use of HB sperm in ICSI was associated with improved CPR. The current study represents the single largest prospective, multicenter, double-blinded and randomized controlled trial to evaluate the use of hyaluronan in the selection of sperm for ICSI.

Design: Using the hyaluronan binding assay, an HB score was determined for the fresh or initial (I-HB) and processed or final semen specimen (F-HB). Patients were classified as >65% or ≤ 65% I-HB and stratified accordingly. Patients with I-HB scores ≤ 65% were randomized into control and HB selection (HYAL) groups whereas patients with I-HB >65% were randomized to non-participatory (NP), control or HYAL groups, in a ratio of 2:1:1. The NP group was included in the >65% study arm to balance the higher prevalence of patients with I-HB scores >65%. In the control group, oocytes received sperm selected via the conventional assessment of motility and morphology. In the HYAL group, HB sperm meeting the same visual criteria were selected for injection. Patient participants and clinical care providers were blinded to group assignment.

Participants and setting: Eight hundred two couples treated with ICSI in 10 private and hospital-based IVF programs were enrolled in this study. Of the 484 patients stratified to the I-HB > 65% arm, 115 participants were randomized to the control group, 122 participants were randomized to the HYAL group and 247 participants were randomized to the NP group. Of the 318 patients stratified to the I-HB ≤ 65% arm, 164 participants were randomized to the control group and 154 participants were randomized to the HYAL group.

Main results and the role of chance: HYAL patients with an F-HB score ≤ 65% demonstrated an IR of 37.4% compared with 30.7% for control [n = 63, 58, P > 0.05, (95% CI of the difference -7.7 to 21.3)]. In addition, the CPR associated with patients randomized to the HYAL group was 50.8% when compared with 37.9% for those randomized to the control group (n = 63, 58, P > 0.05). The 12.9% difference was associated with a risk ratio (RR) of 1.340 (RR 95% CI 0.89-2.0). HYAL patients with I-HB and F-HB scores ≤ 65% revealed a statistically significant reduction in their PLR (I-HB: 3.3 versus 15.1%, n = 73, 60, P = 0.021, RR of 0.22 (RR 95% CI 0.05-0.96) (F-HB: 0.0%, 18.5%, n = 27, 32, P = 0.016, RR not applicable due to 0.0% value) over control patients. The study was originally planned to have 200 participants per arm providing 86.1% power to detect an increase in CPR from 35 to 50% at α = 0.05 but was stopped early for financial reasons. As a pilot study had demonstrated that sperm preparation protocols may increase the HB score, the design of the current study incorporated a priori collection and analysis of the data by both the I-HB and the F-HB scores. Analysis by both the I-HB and F-HB score acknowledged the potential impact of sperm preparation protocols.

Bias, confounding and other reasons for caution: Selection bias was controlled by randomization. Geographic and seasonal bias was controlled by recruiting from 10 geographically unique sites and by sampling over a 2-year period. The potential for population effect was controlled by adjusting for higher prevalence rates of >65% I-HB that naturally occur by adding the NP arm and to concurrently recruit >65% and ≤ 65% I-HB subjects. Monitoring and site audits occurred regularly to ensure standardization of data collection, adherence to the study protocol and subject recruitment. Subgroup analysis based on the F-HB score was envisaged in the study design.

Generalizability to other populations: The study included clinics using different sperm preparation methods, located in different regions of the USA and proceeded in every month of the year. Therefore, the results are widely applicable.

Trial registration: ClinicalTrials.gov NCT00741494.

Figures

Figure 1
Figure 1
Study design and patient randomization.
Figure 2
Figure 2
Study design and patient randomization.
Figure 3
Figure 3
A: Implantation rate. B: Clinical pregnancy rate.
Figure 4
Figure 4
A: Pregnancy loss rate by I-HB score. B: Pregnancy loss rate by F-HB score.

References

    1. Allen JW, Dix DJ, Collins BW, Merrick BA, He C, Selkirk JK, Poorman-Allen P, Dresser M, Eddy E. Hsp70-2 is part of the synaptonemal complex in mouse and hamster spermatocytes. Chromosoma. 1996;104:414–421. .
    1. Benchaib M, Braun V, Lornage J, Hadj S, Salle B, Lejeune H, Guerin J. Sperm DNA fragmentation decreases the pregnancy rate in an assisted reproductive technique. Hum Reprod. 2003;18:1023–1028. .
    1. Bonduelle M, Van Assche E, Joris H, Keymolen K, Devroey P, Van Steirteghem A, Liebaers I. Prenatal testing in ICSI pregnancies: incidence of chromosomal anomalies in 1586 karyotypes and relation to sperm parameters. Hum Reprod. 2002;17:2600–2614. .
    1. Braude P, Bolton V, Moore S. Human gene expression first occurs between the four and eight-cell stages of preimplantation development. Nature. 1988;332:459–461. .
    1. Bungum M, Humaidan P, Axmon A, Spano M, Bungum L, Erenpreiss J, Giwercman A. Sperm DNA integrity assessment in prediction of assisted reproduction technology outcome. Hum Reprod. 2007;22:174–179. .
    1. Carrell DT, Emery BR, Hammoud S. Altered protamine expression and diminished spermatogenesis: what is the link? Hum Reprod Update. 2007;13:313–327. .
    1. Cayli S, Sakkas D, Vigue L, Demir R, Huszar G. Cellular maturity and apoptosis in human sperm: creatine kinase, caspase-3 and Bclx expression in mature and diminished maturity spermatozoa. Mol Hum Reprod. 2004;10:365–372. .
    1. Celik-Ozenci C, Jakab A, Kovacs T, Catalanotti J, Demir R, Bray-Ward P, Ward D, Huszar G. Sperm selection for ICSI: shape properties do not predict the absence or presence of numerical chromosomal aberrations. Hum Reprod. 2004;19:2052–2059. .
    1. Dix DJ, Allen JW, Collins BW, Mori C, Nakamura N, Poorman-Allen P. Targeted gene disruption of Hsp70–2 results in failed meiosis, germ cell apoptosis, and male infertility. Proc Natl Acad Sci USA. 1996;93:3264–3268. .
    1. Eddy EM. Role of heat shock protein Hsp70–2 in spermatogenesis. Rev Reprod. 1999;4:23–30.
    1. Ergur A, Dokras A, Giraldo J, Habana A, Kovanci E, Huszar G. Sperm maturity and treatment choice of in vitro fertilization (IVF) or intracytoplasmic sperm injection: diminished sperm HspA2 chaperone levels predict IVF failure. Fertil Steril. 2002;77:910–918. .
    1. Huszar G. Process and system for selection of mature sperm by surface membrane determinants for assisted reproduction. 1999. U.S. Patent 5,897,988.
    1. Huszar G. Sperm testing and ICSI selection by hyaluronic acid binding: the hyaluronic acid-coated glass slide and petri dish in the andrology and IVF laboratories. In: Nagy ZP, Varghese AC, Agarwal A, editors. Practical Manual of In Vitro Fertilization: Advanced Methods and Novel Devices. New York: Springer; 2012. pp. 241–257.
    1. Huszar G, Vigue L. Incomplete development of human spermatozoa is associated with increased creatine phosphokinase concentration and abnormal head morphology. Mol Reprod Dev. 1993;34:292–298. .
    1. Huszar G, Vigue L, Morphed M. Sperm creatine phosphokinase M-isoform ratios and fertilizing potential of men: a blinded study of 84 couples treated with in vitro fertilization. Fertil Steril. 1992;57:882–888.
    1. Huszar G, Vique L, Oehninger S. Creatine kinase immunocytochemistry of human sperm-hemizona complexes: selective binding of sperm with mature creatine kinase-staining pattern. Fertil Steril. 1994;61:136–142.
    1. Huszar G, Sbracia M, Vigue L, Miller DJ, Shur BD. Sperm plasma membrane remodeling during spermiogenetic maturation in men: relationship among plasma membrane beta 1,4-galactosyltransferase, cytoplasmic creatine phosphokinase, and creatine phosphokinase isoform ratios. Biol Reprod. 1997;56:1020–1024. .
    1. Huszar G, Stone K, Dix D, Vigue L. Putative creatine kinase M-isoform in human sperm is identified as the 70-kilodalton heat shock protein HspA2. Biol Reprod. 2000;63:925–932. .
    1. Huszar G, Ozenci C, Cayli S, Zavaczki Z, Hansch E, Vique L. Hyaluronic acid binding by human sperm indicates cellular maturity, viability and unreacted acrosomal status. Fertil Steril. 2003;79(Suppl. 3):1616–1624. .
    1. Jakab A, Sakkas D, Delpiano E, Cayli S, Kovanci E, Ward D, Ravelli A, Huszar G. Intracytoplasmic sperm injection: a novel selection method for sperm with normal frequency of chromosomal aneuploidies. Fertil Steril. 2005;84:1665–1673. .
    1. Kovanci E, Kovacs T, Moretti E, Bray-Ward P, Ward DC, Huszar G. FISH assessment of aneuploidy frequencies in mature and immature human spermatozoa classified by the absence or presence of cytoplasmic retention. Hum Reprod. 2001;16:1209–1217. .
    1. Origio, Inc. 2011. Instructions for Use: HBA® Sperm Hyaluronan Binding Assay . (21 November 2012, date last accessed)
    1. Origio, Inc. 2012. PICSI® Sperm Selection Device: Instructions for Use . (21 November 2012, date last accessed)
    1. Palermo GD, Neri QV, Hariprashad JJ, Davis OK, Veeck LL, Rosenwaks Z. ICSI and its outcome. Semin Reprod Med. 2000;18:161–169. .
    1. Parmegiani L, Cognigni GE, Ciampaglia W, Bernardi S, Troilo E, Filicori M. ‘Physiologic ICSI:’ Hyaluronic acid (HA) favors selection of sperm without DNA fragmentation and with normal nucleus, resulting in improvement of embryo quality. Fertil Steril. 2010;93:598–604. .
    1. Sakkas D, Mariethoz E, St John JC. Abnormal sperm parameters in humans are indicative of an abortive apoptotic mechanism linked to the Fas mediated pathway. Exp Cell Res. 1999;251:350–351. .
    1. Seli E, Sakkas D. Spermatozoal nuclear determinants of reproductive outcome: implications for ART. Hum Reprod Update. 2005;11:337–349. .
    1. Simpson JL, Lamb DJ. Genetic effects of intracytoplasmic sperm injection. Semin Reprod Med. 2001;19:239–249. .
    1. Tesarik J, Kopecny V, Plachot M, Mandelbaum J. Activation of nucleolar and extranucleolar RNA synthesis and changes in ribosomal content of human embryos developing in vitro. J Reprod Fertil. 1986;78:463–470. .
    1. Van Steirteghem A, Bonduelle M, Devroey P, Liebaers I. Follow-up of children born after ICSI. Hum Reprod Update. 2002;8:111–116. .
    1. Virro MR, Larson-Cook KL, Evenson DP. Sperm chromatin structure assay (SCSA) parameters are related to fertilization, blastocyst development, and ongoing pregnancy in in vitro fertilization and intracytoplasmic sperm injection cycles. Fertil Steril. 2004;81:1289–1295. .
    1. Worrilow KC, Huynh HT, Bower J, Peters AJ, Johnston JB. The clinical impact associated with the use of PICSI-derived embryos. Fertil Steril. 2006;86(Suppl. 3):S62. .
    1. Worrilow KC, Huynh HT, Bowers JB, Anderson A, Schillings W, Crain J. PICSI versus ICSI: Statistically significant improvement in clinical outcomes in 240 in vitro fertilization (IVF) patients. Fertil Steril. 2007;88(Suppl. 1):S37. .
    1. Yagci A, Murk W, Stronk J, Huszar G. Spermatozoa bound to solid state hyaluronic acid show chromatin structure with high DNA chain integrity: An acridine orange fluorescence study. J Androl. 2010;31:566–572. .
    1. Zavaczki Z, Celik-Ozenci C, Ovari L, Jakab A, Sati G, Ward D, Huszar G. Dimensional assessment of X-bearing and Y-bearing haploid and disomic human sperm with the use of fluorescence in situ hybridization and objective morphometry. Fertil Steril. 2006;85:121–127. .
    1. Zini A, Borman JM, Belzile E, Ciampi A. Sperm DNA damage is associated with an increased risk of pregnancy loss after IVF and ICSI: Systematic review and meta-analysis. Hum Reprod. 2008;23:2663–2668. .

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する